Early research (Phase 1)Study completedNCT00623870What this trial is testingRO5045337 [RG7112] in Patients With Hematologic Neoplasms.Who this might be right forHematologic Neoplasms Hoffmann-La Roche 116
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07259161What this trial is testingModified Conditioning Regimen for CML-BPWho this might be right forCML,Blast PhaseHSCT Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)Study completedNCT00683046What this trial is testingT-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesWho this might be right forAcute Myelogenous LeukemiaLymphoid LeukemiaChronic Myelogenous Leukemia+6 more University of Chicago 204
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Testing effectiveness (Phase 2)Study completedNCT00627666What this trial is testingDonor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Asan Medical Center 52
Early research (Phase 1)Study completedNCT00964873What this trial is testingThe HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBlast-phase Chronic Myelogenous Leukemia+3 more Synta Pharmaceuticals Corp. 29
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Post-approval studies (Phase 4)Study completedNCT01368523What this trial is testingStudy of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 TrialWho this might be right forChronic Myelogenous Leukemia Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)UnknownNCT00335868What this trial is testingPHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL TherapyWho this might be right forLeukemia Jonsson Comprehensive Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00036738What this trial is testingFludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blastic Phase+7 more Fred Hutchinson Cancer Center 28
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Early research (Phase 1)Study completedNCT00066326What this trial is testingImatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01904136What this trial is testingNatural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Gene Mutations+6 more M.D. Anderson Cancer Center 54
Early research (Phase 1)Study completedNCT00053144What this trial is testingIrinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaWho this might be right forLeukemia Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00015834What this trial is testingSTI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveRelapsing Chronic Myelogenous Leukemia National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00068718What this trial is testingDonor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell TransplantWho this might be right forBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+3 more Fred Hutchinson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00002833What this trial is testingPeripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT00003396What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Study completedNCT00003913What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic DiseaseWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 390
Testing effectiveness (Phase 2)Study completedNCT00611351What this trial is testingBusulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+4 more University of Nebraska 5